Skip to content

Clinical trials

Obesity trials in the United Arab Emirates

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Obesity Country / region: United Arab Emirates Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20122
20131
20151
20163
20183
20192
20201
20221
20233
20251
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Unknown status6
Recruiting2
Active, not recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S4
Emirates Health Services (EHS)2
Imperial College London Diabetes Centre2
Institute for Healthier Living Abu Dhabi2
United Arab Emirates University2
Zayed University2
American University of Sharfah1
Corniche Hospital1
GT Metabolic Solutions, Inc.1
Halia Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Obesity22
Overweight6
Diabetes Mellitus, Type 24
Diabetes Mellitus2
Hypertension2
Binge-Eating Disorder1
Diabetes, Gestational1
Dysbiosis1
Dyslipidemias1
Glucose Intolerance1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.